Treatment and Outcomes for Primary Cutaneous Extramedullary Plasmacytoma: A Case Series
Author(s) -
Derek S. Tsang,
Liu Le,
Vishal Kukreti,
A. Sun
Publication year - 2016
Publication title -
current oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.053
H-Index - 51
eISSN - 1718-7729
pISSN - 1198-0052
DOI - 10.3747/co.23.3288
Subject(s) - medicine , hazard ratio , multiple myeloma , retrospective cohort study , radiation therapy , plasmacytoma , surgery , disease , confidence interval
Primary cutaneous plasmacytoma (pcp) is a rare disease, with few studies to guide therapy. Our primary study objective was to define treatments used for pcp; a secondary objective was to describe outcomes of patients, including disease recurrence and death.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom